Home Medicine Hyperinsulinism–hyperammonemia syndrome in two Peruvian children with refractory epilepsy
Article
Licensed
Unlicensed Requires Authentication

Hyperinsulinism–hyperammonemia syndrome in two Peruvian children with refractory epilepsy

  • Miguel Angel De los Santos-La Torre ORCID logo EMAIL logo , Carlos Manuel Del Águila-Villar ORCID logo , Luis Rómulo Lu-de Lama ORCID logo , Oswaldo Nuñez-Almache ORCID logo , Eliana Manuela Chávez-Tejada ORCID logo , Oscar Antonio Espinoza-Robles ORCID logo , Paola Marianella Pinto-Ibárcena ORCID logo , Martha Rosario Calagua-Quispe ORCID logo , Pamela Miluska Azabache-Tafur ORCID logo and Rosa María Tucto-Manchego ORCID logo
Published/Copyright: December 8, 2022

Abstract

Objectives

Congenital hyperinsulinism (HI) is a heterogeneous clinical disorder with great variability in its clinical phenotype, and to date, pathogenic variants in 23 genes have been recognized.  Hyperinsulinism-hyperammonemia syndrome (HI/HA) is the second most frequent cause of this disease that shows an autosomal dominant pattern and is caused by an activating mutation of the GLUD1 gene, which responds favorably to the use of diazoxide. HI/HA syndrome presents with fasting hypoglycemia; postprandial hypoglycemia, especially in those with a high protein content (leucine); and persistent mild hyperammonemia. Neurological abnormalities, in the form of epilepsy or neurodevelopmental delay, are observed in a high percentage of patients; therefore, timely diagnosis is crucial for proper management.

Case presentation

We report the clinical presentation of two Peruvian children that presented with epilepsy whose genetic analysis revealed a missense mutation in the GLUD1 gene, one within exon 11, at 22% mosaicism; and another within exon 7, as well as their response to diazoxide therapy. To the best of our knowledge, these are the first two cases of HI/HA syndrome reported in Peru.

Conclusions

HI/HA syndrome went unnoticed, because hypoglycemia was missed and were considered partially controlled epilepsies. A failure to recognize hypoglycemic seizures will delay diagnosis and adequate treatment, so a proper investigation could avoid irreversible neurological damage.


Corresponding author: Miguel Angel De los Santos-La Torre, Department of Endocrinology and Metabolism of The Child’s Health National Institute, Instituto Nacional de Salud del Niño, Brazil Avenue 600, 15083, Lima, Peru, Phone: +5113300066, 2380, E-mail:

Acknowledgments

We would like to thank Professor Sarah Flanagan and her genetic and biomolecular team at the Genomic Laboratory in University of Exeter, Medical School, UK, for their invaluable support with conducting the genetic analysis for our patients and facilitating us in the proper diagnosis and treatment of the patients.

  1. Research funding: The authors declare no financial support was received.

  2. Author contribution: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Verbal and written informed consent was obtained from the parents of the patients.

  5. Ethical approval: The local Institutional Review Board approved this report.

References

1. Palladino, AA, Bennett, MJ, Stanley, CA. Hyperinsulinism in the infancy and childhood: when an insulin level is not always enough. Clin Chem 2008;54:256–63. https://doi.org/10.1373/clinchem.2007.098988.Search in Google Scholar PubMed

2. Boodhansingh, KE, Rosenfeld, E, Lord, K, Adzick, NS, Bhatti, T, Ganguly, A, et al.. Mosaic GLUD1 mutations associated with hyperinsulinism hyperammonemia syndrome. Horm Res Paediatr 2022. https://doi.org/10.1159/000526203 [Epub ahead of print].Search in Google Scholar PubMed PubMed Central

3. Yau, D, Stanley, C. Diazoxide-responsive forms of congenital hyperinsulinism. In: Leon-Crutchlow, D, Stanley, C, editor. Congenital hyperinsulinism a practical guide to diagnosis and management. Switzerland: Springer Nature; 2019:19–24 pp.10.1007/978-3-030-02961-6_2Search in Google Scholar

4. Roy, K, Satapathy, AK, Houhton, JAL, Flanagan, SE, Radha, V, Mohan, V, et al.. Congenital hyperinsulinemic hypoglycemia and hyperammonemia due to pathogenic variants in GLUD1. Indian J Pediatr 2019;86:1051–3. https://doi.org/10.1007/s12098-019-02980-x.Search in Google Scholar PubMed

5. Sang, Y, Xu, Z, Liu, M, Yan, J, Wu, Y, Zhu, C, et al.. Mutational analysis of ABCC8, KCNJ11, GLUD1, HNF4A and GCK genes in 30 Chinese patients with congenital hyperinsulinism. Endocr J 2014;61:901–10. https://doi.org/10.1507/endocrj.ej13-0398.Search in Google Scholar PubMed

6. Sharma, R, Roy, K, Satapathy, AK, Kumar, A, Nanda, PM, Damle, N, et al.. Molecular characterization and management of congenital hyperinsulinism: a tertiary centre experience. Indian Pediatr 2022;59:105–9. https://doi.org/10.1007/s13312-022-2438-0.Search in Google Scholar PubMed PubMed Central

7. Kapoor, RR, Flanagan, SE, Arya, VB, Shield, JP, Ellard, S, Hussain, K. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol 2013;168:557–64. https://doi.org/10.1530/eje-12-0673.Search in Google Scholar PubMed PubMed Central

8. Ninkovic, D, Sarnavka, V, Basnec, A, Cuk, M, Ramadz, DP, Fumic, K, et al.. Hyperinsulinism-hyperammonemia syndrome: a de novo mutation of the GLUD1 gene in twins and a review of the literature. J Pediatr Endocrinol Metab 2016;29:1083–8. https://doi.org/10.1515/jpem-2016-0086.Search in Google Scholar PubMed

9. Brandt, A, Agarwal, N, Giri, D, Yung, Z, Didi, M, Senniappan, S. Hyperinsulinism hyperammonemia (HI/HA) syndrome due to GLUD1 mutation: phenotypic variations ranging from late presentation to spontaneous resolution. J Pediatr Endocrinol Metab 2020;33:675–9. https://doi.org/10.1515/jpem-2019-0416.Search in Google Scholar PubMed

10. Stanley, CA. Perspective on the genetics and diagnosis of congenital hyperinsulinism disorders. J Clin Endocrinol Metab 2016;101:815–26. https://doi.org/10.1210/jc.2015-3651.Search in Google Scholar PubMed PubMed Central

11. Snider, KE, Becker, S, Boyajian, L, Shyng, SL, MacMullen, C, Hughes, N, et al.. Genotype and phenotype correlations in 417 Children with congenital hyperinsulinism. J Clin Endocrinol Metab 2013;98:E355–63. https://doi.org/10.1210/jc.2012-2169.Search in Google Scholar PubMed PubMed Central

12. Güemes, M, Hussain, K. Hyperinsulinemic hypoglycemia. Pediatr Clin 2015;62:1017–36. https://doi.org/10.1016/j.pcl.2015.04.010.Search in Google Scholar PubMed

13. Lord, K, De León, D. Hyperinsulinism in the neonate. Clin Perinatol 2018;45:61–74. https://doi.org/10.1016/j.clp.2017.10.007.Search in Google Scholar PubMed

14. Luczkowska, K, Stekelenburg, C, Sloan-Bena, F, Ranza, E, Gastañdo, G, Schwitzgebel, V, et al.. Hyperinsulinism associated with GLUD1 mutation: allosteric regulation and functional characterization of p.G446V glutamate dehydrogenase. Hum Genom 2020;14:9. https://doi.org/10.1186/s40246-020-00262-8.Search in Google Scholar PubMed PubMed Central

15. Giri, D, Hawton, K, Senniappan, S. Congenital hyperinsulinism: recent updates on molecular mechanisms, diagnosis and management. J Pediatr Endocrinol Metab 2021;35:279–96.10.1515/jpem-2021-0369Search in Google Scholar PubMed

Received: 2022-09-27
Revised: 2022-11-13
Accepted: 2022-11-21
Published Online: 2022-12-08
Published in Print: 2023-02-23

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. One half-century of advances in the evaluation and management of disorders of bone and mineral metabolism in children and adolescents
  4. Original Articles
  5. Safety and user experience with off-label use of a flash glucose monitor (FreeStyle Libre® 1) among very young children with type 1 diabetes mellitus
  6. Sonic hedgehog N-terminal level correlates with adiponectin level and insulin resistance in adolescents
  7. Elevated amylase and lipase levels in patients with DKA followed in the pediatric intensive care unit
  8. The relationship between alexithymia, health literacy, and diet quality in obese adolescents
  9. The role of the deficiency of vitamin B12 and folic acid on homocysteinemia in children with Turner syndrome
  10. Clinical spectrum and diagnostic challenges of vitamin D dependent rickets type 1A (VDDR1A) caused by CYP27B1 mutation in resource limited countries
  11. Comparative characteristics of developing morphofunctional features of schoolchildren from different climatic and geographical regions
  12. Leucine tolerance in children with MSUD is not correlated with plasma leucine levels at diagnosis
  13. Outcomes of children with severe diabetic ketoacidosis managed outside of a pediatric intensive care unit
  14. Thiamine status during treatment of diabetic ketoacidosis in children – tertiary care centre experience
  15. Premature adrenarche in Prader–Willi syndrome is associated with accelerated pre-pubertal growth and advanced bone age
  16. Short Communication
  17. Diagnosis of adrenal insufficiency in children: a survey among pediatric endocrinologists in North America
  18. Case Reports
  19. Pediatric growth hormone and prolactin-secreting tumor associated with an AIP mutation and a MEN1 variant of uncertain significance
  20. Two cases of MEGDHEL syndrome diagnosed with hyperammonemia
  21. Hyperinsulinism–hyperammonemia syndrome in two Peruvian children with refractory epilepsy
  22. A case report of a young boy with low renin and high aldosterone levels induced by Liddle syndrome who was previously misdiagnosed with primary aldosteronism
  23. Adolescents with type 1 diabetes vs. hybrid closed loop systems: a case series of patients’ behaviour that challenges the algorithm.
Downloaded on 8.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2022-0490/html
Scroll to top button